Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction

Merck KGaA

www.emdgroup.com/en

Latest From Merck KGaA

Bookmark
  • Analysis

Embracing China 2.0: AZ, Merck KGaA Set Up Funds, J&J Steps Up Digital Push

By Brian Yang

AstraZeneca has pledged $1bn to a healthcare fund to support local innovation in China, joining big pharma peers J&J and Merck KGaA in fresh moves to embrace this market, where a new wave of digital technology transformation and fast-shifting trends now favor novel new therapies and the rise of local health start-ups

China Innovation
Bookmark
  • Analysis

ObsEva Gives Up On IVF Drug As Phase III Study Fails

By Alex Shimmings

Shares plummet as ObsEva announces it is discontinuing its IVF program for nolasiban after disappointing Phase III data from a European confirmatory study.

Clinical Trials Companies
Bookmark
  • Analysis

GSK Gears Up For Three Cancer Launches In 2020

By Andrew McConaghie
After selling off its oncology franchise just five years ago, GSK is poised to re-enter the fray - and is preparing its commercial teams for battle.
Commercial FDA
Bookmark
  • News

Mixed Data For Merck KGaA's Disease-Modifying OA Drug

By Kevin Grogan
Sprifermin could be the first drug to affect the underlying disease process in osteoarthritis but data show no significant improvement in symptoms.
Inflammation Clinical Trials
See All

Company Information

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By